nav-left cat-right
cat-right

XL-protein Signs Licensing Agreement with MSD Anim...

FREISING, GERMANY, February 12, 2015 – XL-protein GmbH, Germany, a privately owned biopharmaceutical company, announced today that they have entered into a license agreement with MSD Animal Health (known as Merck Animal Health in the USA and Canada) to develop PASylated biopharmaceuticals for use in animal health. This license agreement follows a research collaboration between the two companies which began in 2012 and...

Seegene Receives US Patent for TOCE Technology

Gaithersburg, Maryland and SEOUL, Korea, November 19, 2014 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that it has been issued a United States Patent, No. 8,809,239, for its tagging oligonucleotide capture and extension (TOCE™) technology, which enables highly multiplexed target amplification and detection in a single tube. TOCE™ technology is now IP protected in...

Stem cells from human body fat used to deliver tre...

Johns Hopkins researchers say they have successfully used stem cells derived from human body fat to deliver biological treatments directly to the brains of mice with the most common and aggressive form of brain tumor, significantly extending their lives. In the mouse experiments, the Johns Hopkins investigators used mesenchymal stem cells (MSCs) – which have an unexplained ability to seek out cancer and other damaged...

Positing Parkinson’s as an autoimmune diseas...

Parkinson’s disease, like Alzheimer’s disease, is one of the leading neurodegenerative issues being targeted by the biopharmaceutical and life sciences industries today. It is the result of the death of neurons responsible for producing dopamine, which the Parkinson’s Disease Foundation describes as “A chemical messenger that regulates movement by assisting in the effective communication (transmission) of...

Novavax, U. of Maryland report positive preclinica...

With the arrival of Middle East respiratory syndrome coronavirus in the U.S. and a rising death toll in Saudi Arabia, a vaccine designed by Novavax ($NVAX) and the University of Maryland has shown promise in blocking the infection in animals. In a study published in Vaccine, researchers describe a novel method to rapidly develop vaccines against previously unknown viruses, such as MERS-CoV, which emerge suddenly and cause...

Harvard’s bone marrow-on-a-chip could replac...

Scientists at Harvard’s Wyss Institute for Biologically Inspired Engineering have unveiled their newest tool for drug testing, dubbed “bone marrow-on-a-chip,” the first device of its kind that mimics the structure, functions and cellular make-up of bone marrow. Bone marrow is made up of complex tissue and has, up until now, primarily been studied intact in living animals. Like the Wyss Institute’s...
Page 1 of 4012345...102030...Last »